Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Open-label, Two-period, Double-crossover Comparative Pharmacokinetic (PK) Study of a Single Oral Dose of Ramelteon Modified-Release Tablets and Ramelteon Tablets in Chinese Healthy Subjects

NCT06890715 is registered in ClinicalTrials.gov with Overseas Pharmaceuticals, Ltd. as lead sponsor.

NCT NCT06890715
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06890715 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Open-label, Two-period, Double-crossover Comparative Pharmacokinetic (PK) Study of a Single Oral Dose of Ramelteon Modified-Release Tablets and Ramelteon Tablets in Chinese Healthy Subjects
Lead sponsor
Overseas Pharmaceuticals, Ltd.
Phase
Phase 1
Overall status
Completed
Start date
June 24, 2024
Completion date
July 8, 2024
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic insomnia characterized